BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
Becton, Dickinson and Company BDX, popularly known as BD, has announced the commercial release of the BD Neopak XtraFlow Glass Prefillable Syringe, expanding its Neopak Glass Prefillable Syringe ...
Franklin Lakes-based BD (Becton, Dickinson and Company), a leading global medical technology company, on Tuesday announced plans to invest approximately $1.2 billion over a four-year period to expand ...
Becton, Dickinson has won a partial appeal of a $5 million patent-infringement verdict in favor of Retractable Technologies on technology used to protect healthcare workers from accidental needle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results